BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART;VALUE=DATE:20230101
TZNAME:UTC
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Date: Thursday 12th January 2023\nTime: \;15:00-16:30 GMT |
10:00-11:30 EST\nOverview\nThe DIA Statistics and Data Science Virtual Jo
urnal Club are pleased to announce a joint webinar with the Statisticians
in the Pharmaceutical Industry (PSI) \; journal club. The title is Bio
marker Adaptive Designs. The webinar will be held on Dec. 16th 12:00-1:30p
m EST (4:00-5.30pm GMT). \;  \;Dr. Shufang Liu (Astellas Pharma In
c.) \; and Dr. Weidong Zhang (Jounce Therapeutics) will present their
recent publications and Dr. Sue-Jane Wang (FDA) will the discussant. \
;\nRegistration\nThis event is open to both Members and Non-Members of PSI
.\nREGISTER HERE: \;https://diaglobal.zoom.us/webinar/register/WN_iL56
FKmZSUSfpfy-e0OOpQ\n\n\nPresenters\n1. An Adaptive Biomarker Basket Design
in Phase II Oncology\nShufang Liu\, Kentaro Takeda\, Alan Rong\nPharmaceu
tical Statistics. 2022\; 1-15\n2. Statistical and Operational Consideratio
ns for 2 Stage Adaptive Designs with Simultaneous Evaluation of Overall an
d Marker Selected Populations in Oncology Confirmatory Trials\nWeidong Zha
ng\, Sunhee Ro et al\nTherapeutic Innovations &\; Regulatory Science. 2
022\; 56: 552-560\n \;\nDiscussant:\nDr. Sue-Jane Wang\n \;\n 
\;
DTEND:20221216T173000Z
DTSTAMP:20240328T150820Z
DTSTART:20221216T160000Z
LOCATION:
SEQUENCE:0
SUMMARY:PSI Journal Club: Biomarker Adaptive Designs
UID:RFCALITEM638472353003675383
X-ALT-DESC;FMTTYPE=text/html:Date: Thursday 12th January 2
023
\nTime: \;15:00-16:30 GMT | 10:00-11:30 EST<
br />\n
The DIA Statistics and Data Science Virtual J ournal Club are pleased to announce a joint webinar with the Statisticians in the Pharmaceutical Industry (PSI) \; journal club. The title is Bi omarker Adaptive Designs. The webinar will be held on Dec. 16th 12:00-1:30 pm EST (4:00-5.30pm GMT). \;  \;Dr. Shufang Liu (Astellas Pharma I nc.) \; and Dr. Weidong Zhang (Jounce Therapeutics) will present their recent publications and Dr. Sue-Jane Wang (FDA) will the discussant.  \;
\nThis event is open to both Members and N
on-Members of PSI.
\nREGISTER HERE: \;https://diaglobal.zoom.us/webinar/register/WN_iL56FKmZSUSfpfy-
e0OOpQ
\n
\n
1. An Adaptive Biomarker B
asket Design in Phase II Oncology
\nShufang Liu\,
Kentaro Takeda\, Alan Rong
\nPharmaceutical Statistics.
2022\; 1-15
2. Statist
ical and Operational Considerations for 2 Stage Adaptive Designs with Simu
ltaneous Evaluation of Overall and Marker Selected Populations in Oncology
Confirmatory Trials
\nWeidong Zhang\, Sunhee Ro e
t al
\nTherapeutic Innovations &\; Regulatory Scienc
e. 2022\; 56: 552-560
\n \;
\nDiscussant:
\nDr. Sue-Jane Wang<
/strong>
 \;
END:VEVENT END:VCALENDAR